DAMMACCO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.266
EU - Europa 298
AS - Asia 203
Totale 1.767
Nazione #
US - Stati Uniti d'America 1.263
CN - Cina 136
SE - Svezia 87
IT - Italia 59
SG - Singapore 48
UA - Ucraina 30
GB - Regno Unito 27
DE - Germania 25
FI - Finlandia 24
RU - Federazione Russa 20
BE - Belgio 15
FR - Francia 5
IR - Iran 5
IN - India 4
VN - Vietnam 4
CA - Canada 3
TR - Turchia 3
CZ - Repubblica Ceca 2
BG - Bulgaria 1
CH - Svizzera 1
IL - Israele 1
JP - Giappone 1
ME - Montenegro 1
NL - Olanda 1
PK - Pakistan 1
Totale 1.767
Città #
Chandler 146
Fairfield 143
Ann Arbor 117
Houston 106
Woodbridge 97
Ashburn 82
Jacksonville 69
Nyköping 68
Seattle 68
Cambridge 51
Wilmington 49
Beijing 46
Singapore 43
New York 28
Bari 27
Roxbury 27
Nanjing 26
Lawrence 23
Inglewood 18
Brussels 15
Des Moines 15
Princeton 14
Boardman 12
Dearborn 9
Jiaxing 9
Brooklyn 8
Nanchang 7
San Diego 7
San Mateo 7
Augusta 6
Changsha 6
Leawood 6
Monmouth Junction 6
Shenyang 6
Hebei 5
Rome 5
Ardabil 4
Dong Ket 4
Marseille 4
Munich 4
Santa Clara 4
Tianjin 4
Hounslow 3
Lodi 3
Los Angeles 3
Monza 3
Mugla 3
Pune 3
Tappahannock 3
Auburn Hills 2
Brno 2
Grafing 2
Helsinki 2
Ningbo 2
Ostuni 2
Ottawa 2
Prescot 2
Taizhou 2
Chicago 1
Clearwater 1
Dongguan 1
Falkenstein 1
Guangzhou 1
Guilin 1
Haikou 1
Hauppauge 1
Islamabad 1
Jerusalem 1
Jinan 1
Kunming 1
Lethbridge 1
London 1
Mumbai 1
Naples 1
Noicattaro 1
Paris 1
Podgorica 1
Qingdao 1
Redmond 1
Redwood City 1
Simi Valley 1
Sofia 1
Tokyo 1
Washington 1
Wuppertal 1
Wuxi 1
Yiwu 1
Totale 1.469
Nome #
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 124
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques 110
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 109
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 105
Autoantibodies to intracellular antigens: generation and pathogenetic role 104
Goodpasture's disease: a report of ten cases and a review of the literature. 96
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 87
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 84
Ibridizzazione in situ non isotopica. Attualità e prospettive 75
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 69
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 67
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 65
null 64
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 56
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab 51
Cancrini, Caterina, et al. "Clinical features and follow-up in patients with 22q11. 2 deletion syndrome." The Journal of pediatrics 164.6 (2014): 1475-1480. 50
null 47
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. 46
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies (Ab) and identifies a subset of anti-CENP Ab positive systemic sclerosis patients. 44
null 41
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 41
null 39
null 36
null 35
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 32
null 30
Flogosis and Heart involvement in Large Vessel Vasculitis 27
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 25
Soluble CD4 and commercial immunoglobulins 20
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression 19
Dendritic cells are recruited to the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T cell killing. 18
null 17
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 15
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 5
Totale 1.853
Categoria #
all - tutte 8.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 0 0 30 23 41 36 42 10
2020/2021316 30 15 23 13 34 12 33 20 25 31 64 16
2021/2022201 11 27 1 16 7 7 8 17 8 11 41 47
2022/2023341 51 56 27 31 35 47 4 34 35 3 10 8
2023/2024140 16 16 2 11 13 44 4 14 1 4 4 11
2024/2025120 13 6 31 16 6 48 0 0 0 0 0 0
Totale 1.853